Eton Pharmaceuticals (NASDAQ:ETON) reported its Q4 earnings results on Thursday, March 14, 2024 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Eton Pharmaceuticals missed estimated earnings by -125.0%, reporting an EPS of $-0.09 versus an estimate of $-0.04.
Revenue was down $1.19 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.08 which was followed by a 15.0% drop in the share price the next day.
Here's a look at Eton Pharmaceuticals's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.10 | -0.09 | -0.14 | 0.01 |
| EPS Actual | -0.02 | 0.18 | -0.10 | 0.04 |
| Revenue Estimate | 6.26M | 6.51M | 4.56M | 9.12M |
| Revenue Actual | 7.03M | 12.00M | 5.30M | 8.50M |
To track all earnings releases for Eton Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.